Literature DB >> 26243544

Sex-Specific Changes in Renal Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 Gene Expression and Enzyme Activity at Birth and Over the First Year of Life.

Kai Chen1, Jianli Bi2, Yixin Su2, Mark C Chappell3, James C Rose4.   

Abstract

OBJECTIVE: Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE2) are key enzymes of the renin-angiotensin system. We investigated developmental changes in renal ACE and ACE2 gene expression and activity in both male and female sheep.
METHODS: Three groups of sheep (fetus, newborn, and adult) were used. Renal ACE and ACE2 activities, messenger RNA (mRNA), and protein expression were studied.
RESULTS: Renal ACE and ACE2 activities increased at 1 year in males, while there were no changes throughout development in females. Renal ACE and ACE2 mRNA and protein showed no sex differences but increased by 1 year of age.
CONCLUSION: There are sex-related differences in the development of renal-converting enzyme activities that may have functional implications in terms of the regulation of blood pressure and renal function in men and women. The difference in the patterns of gene expression and enzyme activity indicates that changes in gene expression may not accurately reflect changes in activity.
© The Author(s) 2015.

Entities:  

Keywords:  angiotensin-converting enzyme; angiotensin-converting enzyme 2; kidney; renin–angiotensin system; sex

Mesh:

Substances:

Year:  2015        PMID: 26243544      PMCID: PMC5933173          DOI: 10.1177/1933719115597760

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  68 in total

1.  Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.

Authors:  Yanfei Qi; Juan Zhang; Colleen T Cole-Jeffrey; Vinayak Shenoy; Andrew Espejo; Mina Hanna; Chunjuan Song; Carl J Pepine; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2013-08-19       Impact factor: 10.190

2.  Estrogen regulation of angiotensin-converting enzyme mRNA.

Authors:  P E Gallagher; P Li; J R Lenhart; M C Chappell; K B Brosnihan
Journal:  Hypertension       Date:  1999-01       Impact factor: 10.190

3.  Glomerular localization and expression of Angiotensin-converting enzyme 2 and Angiotensin-converting enzyme: implications for albuminuria in diabetes.

Authors:  Minghao Ye; Jan Wysocki; Josette William; Maria José Soler; Ivan Cokic; Daniel Batlle
Journal:  J Am Soc Nephrol       Date:  2006-10-04       Impact factor: 10.121

4.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

5.  Role of cortisol in the ontogenic control of pulmonary and renal angiotensin-converting enzyme in fetal sheep near term.

Authors:  A J Forhead; C E Gillespie; A L Fowden
Journal:  J Physiol       Date:  2000-07-15       Impact factor: 5.182

6.  The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep.

Authors:  Kai Chen; Luke C Carey; Jingfang Liu; Nancy K Valego; Stephen B Tatter; James C Rose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-12-16       Impact factor: 3.619

7.  Developmental expression of ACE2 in the SHR kidney: a role in hypertension?

Authors:  C Tikellis; M E Cooper; K Bialkowski; C I Johnston; W C Burns; R A Lew; A I Smith; M C Thomas
Journal:  Kidney Int       Date:  2006-05-17       Impact factor: 10.612

8.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility.

Authors:  C R Esther; T E Howard; E M Marino; J M Goddard; M R Capecchi; K E Bernstein
Journal:  Lab Invest       Date:  1996-05       Impact factor: 5.662

Review 9.  Gender and the progression of chronic renal diseases: does apoptosis make the difference?

Authors:  M T Gandolfo; D Verzola; F Salvatore; G Gianiorio; V Procopio; A Romagnoli; M Giannoni; G Garibotto
Journal:  Minerva Urol Nefrol       Date:  2004-03       Impact factor: 3.720

10.  Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.

Authors:  José A Hernández Prada; Anderson J Ferreira; Michael J Katovich; Vinayak Shenoy; Yanfei Qi; Robson A S Santos; Ronald K Castellano; Andrew J Lampkins; Vladimir Gubala; David A Ostrov; Mohan K Raizada
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

View more
  13 in total

Review 1.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

Review 2.  ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerations.

Authors:  Eric M Snyder; Bruce D Johnson
Journal:  Pharmacogenomics       Date:  2020-06-05       Impact factor: 2.533

3.  Omeprazole use and risk of chronic kidney disease evolution.

Authors:  João Victor Marques Guedes; Jéssica Azevedo Aquino; Tássia Lima Bernardino Castro; Flávio Augusto de Morais; André Oliveira Baldoni; Vinícius Silva Belo; Alba Otoni
Journal:  PLoS One       Date:  2020-03-04       Impact factor: 3.240

Review 4.  Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies.

Authors:  Girish Pathangey; Priyal P Fadadu; Alexandra R Hospodar; Amr E Abbas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-11-25       Impact factor: 5.464

Review 5.  Silence of the Lambs: The Immunological and Molecular Mechanisms of COVID-19 in Children in Comparison with Adults.

Authors:  Francesca Cusenza; Giusy Davino; Tiziana D'Alvano; Alberto Argentiero; Valentina Fainardi; Giovanna Pisi; Nicola Principi; Susanna Esposito
Journal:  Microorganisms       Date:  2021-02-07

6.  Is There a Gender Difference in Clinical Presentation of Renal Hyperparathyroidism and Outcome after Parathyroidectomy?

Authors:  Claudia Bures; Tatjana Skachko; Eva M Dobrindt; Johann Pratschke; Deniz Uluk; Martina T Mogl
Journal:  Visc Med       Date:  2020-01-20

Review 7.  Targeting Multiple Signal Transduction Pathways of SARS-CoV-2: Approaches to COVID-19 Therapeutic Candidates.

Authors:  Sajad Fakhri; Zeinab Nouri; Seyed Zachariah Moradi; Esra Küpeli Akkol; Sana Piri; Eduardo Sobarzo-Sánchez; Mohammad Hosein Farzaei; Javier Echeverría
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

Review 8.  Genetic and epigenetic control of ACE2 expression and its possible role in COVID-19.

Authors:  Rafael Silva Lima; Luiz Paulo Carvalho Rocha; Paula Rocha Moreira
Journal:  Cell Biochem Funct       Date:  2021-06-01       Impact factor: 3.963

Review 9.  Physiological and pathological regulation of ACE2, the SARS-CoV-2 receptor.

Authors:  Yanwei Li; Wei Zhou; Li Yang; Ran You
Journal:  Pharmacol Res       Date:  2020-04-14       Impact factor: 7.658

10.  Do children need a longer time to shed SARS-CoV-2 in stool than adults?

Authors:  Xiang Ma; Liang Su; Yunkui Zhang; Xiuzhen Zhang; Zhongtao Gai; Zhongfa Zhang
Journal:  J Microbiol Immunol Infect       Date:  2020-03-19       Impact factor: 10.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.